Health in Tech, INC Form 4 insider transactions

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,084 shares of common stock on July 15, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 47,217 shares of common stock on July 15, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 28,725 shares of common stock on July 15, 2026.

Health In Tech, Inc. director Sanjay K. Shrestha has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech, Inc. director William D. Howard has executed a Power of Attorney authorizing specific individuals to handle SEC filings related to securities ownership and transactions.

Health In Tech, Inc. director Timothy Hayes has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech's Chief Growth Officer, Zain Hasan, reported a transaction involving the surrender of restricted shares to cover tax obligations.

Health In Tech CEO Tim Johnson reported a transaction involving the surrender of restricted shares to cover tax obligations, impacting his direct beneficial ownership.

Health In Tech's Chief Financial Officer, LinLin Qian, has reported transactions involving Class A Common Stock, including the surrender of shares for tax withholding.

Chief Strategy Officer Jonathan Del Lockett was granted 50,000 restricted shares of Class A Common Stock tied to performance milestones.

CFO LinLin Qian surrendered 23,324 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.

CEO Tim Johnson surrendered 39,924 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.

Chief Growth Officer Zain Hasan surrendered 4,205 shares of Class A Common Stock to satisfy tax obligations related to restricted stock vesting.

CEO Tim Johnson filed an amendment to a previous Form 4 to correct a clerical error regarding his share holdings.

Chief Growth Officer Zain Hasan disposed of 3,448 shares of Class A Common Stock to satisfy tax withholding obligations.

CFO LinLin Qian disposed of 21,480 shares of Class A Common Stock to satisfy tax withholding obligations related to restricted stock vesting.

CEO Tim Johnson surrendered 35,140 shares of Class A Common Stock to satisfy tax withholding obligations following a restricted stock vest.

John McStravock, General Counsel of Health In Tech, Inc., received a grant of 5,000 restricted Class A Common Stock shares.

Sanjay K. Shrestha, a Director at Health In Tech, Inc., reported the acquisition of 13,598 Class A Common Stock shares on April 8, 2026.

Director William D. Howard acquired 13,598 shares of Class A Common Stock in Health In Tech, Inc. on April 8, 2026.

Timothy Hayes, a Director at Health In Tech, Inc., reported the acquisition of 13,598 Class A Common Stock shares on April 8, 2026.

Health In Tech's Chief Growth Officer, Zain Syed Hasan, was granted 200,000 restricted Class A Common Stock shares tied to future company transactions.

Health In Tech CEO Tim Johnson received 1 million restricted Class A Common Stock shares tied to future transactions and continued service, increasing his beneficial ownership.

Health In Tech's CFO, LinLin Qian, was granted 1,000,000 restricted Class A Common Stock shares tied to two proposed company transactions.

Health In Tech, Inc.'s CISO, Michael David Clarkson, was granted 8,000 restricted shares of Class A Common Stock as part of the company's Equity Incentive Plan.

Health In Tech Director William D. Howard reported a forfeiture of 28,159 restricted shares and a new grant of 5,730 restricted shares of Class A Common Stock.

Health In Tech Director Timothy Hayes reported both forfeiture and acquisition of Class A Common Stock, adjusting his beneficial ownership.

Health In Tech Director Sanjay K Shrestha reported an increase in beneficial ownership of Class A Common Stock through new restricted stock grants.

Health In Tech's CEO, Tim Donald Johnson, was granted 80,000 restricted Class A Common Stock shares, aligning his incentives with a new company initiative.

Health In Tech's Chief AI & Marketing Officer, Dustin Plantholt, acquired 50,000 restricted Class A Common Stock shares tied to a new company initiative.